76 related articles for article (PubMed ID: 306029)
1. [Circulating types of human glucagon (author's transl)].
Valverde I
MMW Munch Med Wochenschr; 1978 Mar; 120(12):407-9. PubMed ID: 306029
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma proglucagon-like component with a glucagon-secreting tumor. Effect of streptozotocin.
Danforth DN; Triche T; Doppman JL; Beazley RM; Perrino PV; Recant L
N Engl J Med; 1976 Jul; 295(5):242-5. PubMed ID: 180408
[TBL] [Abstract][Full Text] [Related]
4. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
Valverde I; Lemon HM; Kessinger A; Unger RH
J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of plasma immunoreactive glucagon.
Valverde I; Villanueva ML
Metabolism; 1976 Nov; 25(11 Suppl 1):1393-5. PubMed ID: 979641
[No Abstract] [Full Text] [Related]
7. [Role of high blood glucagon in the reduction of serum levels of triiodothyronine in severe non-thyroid diseases].
Custro N; Scafidi V; Costanzo G; Calanni S
Minerva Endocrinol; 1989; 14(4):221-6. PubMed ID: 2636698
[TBL] [Abstract][Full Text] [Related]
8. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
9. The role of the liver in glucagon metabolism.
Jaspan JB; Huen AH; Morley CG; Moossa AR; Rubenstein AH
J Clin Invest; 1977 Aug; 60(2):421-8. PubMed ID: 874100
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
Guillon J; Charbonnel B
Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
[TBL] [Abstract][Full Text] [Related]
11. Secretion by glucagonomas of a possible glucagon precursor.
Weir GC; Horton ES; Aoki TT; Slovik D; Jaspan J; Rubenstein AH
J Clin Invest; 1977 Feb; 59(2):325-30. PubMed ID: 833279
[TBL] [Abstract][Full Text] [Related]
12. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
J Med; 1986; 17(2):95-108. PubMed ID: 3473162
[TBL] [Abstract][Full Text] [Related]
13. [Plasma glucagon responses to L-arginine in various diseases (author's transl)].
Morita N; Hayakawa H; Kawai K
Radioisotopes; 1978 Apr; 27(4):183-7. PubMed ID: 663316
[No Abstract] [Full Text] [Related]
14. [The course of diabetes and clinical findings in glucagonoma].
Teuscher A; Studer PP; Krebs A; Berger M; Aeberhard P
Schweiz Med Wochenschr; 1979 Sep; 109(35):1273-80. PubMed ID: 524094
[TBL] [Abstract][Full Text] [Related]
15. Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.
Okumura N; Hayakawa T; Yasui K; Noda A; Kondo T; Otsuka K; Nimura Y
Gastroenterol Jpn; 1982; 17(4):347-52. PubMed ID: 7141199
[TBL] [Abstract][Full Text] [Related]
16. Hyperglucagonemia of renal failure.
Bilbrey GL; Faloona GR; White MG; Knochel JP
J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
[TBL] [Abstract][Full Text] [Related]
17. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
Kabadi UM; Kabadi MU; Premachandra BN
Am J Gastroenterol; 1991 Oct; 86(10):1504-7. PubMed ID: 1928046
[TBL] [Abstract][Full Text] [Related]
18. C-peptide pattern in patients with pancreatic cancer.
Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
[TBL] [Abstract][Full Text] [Related]
19. [A study on endocrine disorders in patients with chronic renal failure (author's transl)].
Nango H; Sakai T; Marumo F; Shirataka M
Nihon Jinzo Gakkai Shi; 1981 Feb; 23(2):153-64. PubMed ID: 6265672
[No Abstract] [Full Text] [Related]
20. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
